Materials on the topic
Russian oligarch bought Formula 1 track
French court arrested the Courchevel hotels of the former Russian minister
State Corporation "Rostec" expands cooperation with Latin America
The management of the Memorial Sloan-Kettering Cancer Center in New York was convicted of conspiring with large pharmaceutical companies that paid millions of dollars for access to the latest advances in the fight against cancer.
The Sloan-Kettering Center has 120 research laboratories with the largest clinical trial programs in the world. It accepts 23.5 thousand patients a year. His charity ball in New York is becoming the main event in the secular events calendar of the urban elite, donations to the hospital number in the billions. America’s richest families support this center.
However, gradually the work of the clinic began to be controlled by pharmaceutical companies, who took it under their control with the help of bribed bosses.
The New York Times writes that companies began to include prominent researchers and doctors in their management advice. It is feared that in this way pharmaceutical companies have the opportunity to influence research in order to extract the maximum profit from them. At the same time, the management of oncological institutions receives very decent “bonuses”, shamelessly using the fruits of the labor of their employees.
One of the leading experts in the field of immunotherapy, Dr. Jedd Volchok, was particularly greedy; he established financial relations with more than 30 companies. And Dr. Charles Sowers was also a member of the board of directors of the Swiss pharmaceutical giant Novartis.
Corrupt physicians have neglected the simple truth that the main goal of companies that take them for their own maintenance is to get as much profit as possible from their products, and not to save lives.
It is feared that companies are already manipulating the whole system of developing cancer treatment tools, they are able to influence the clinical trials of drugs in order to get a favorable result for their business, for example, to hide the high risk of adverse complications and inflate the real effectiveness of the drug, not to mention the establishment of ultrahigh prices. on many medications.
12 of the 19 largest pharmaceutical and biotechnology companies have included at least one physician from this medical institution on the governing boards. As a result, the doctors at the Sloan-Kettering Center raised a riot and, at a large general meeting, demanded explanations from their leadership who had lost their conscience.